SlideShare a Scribd company logo
Measures of Disease Frequency
Vidya Ramachandran
National Institute Of Epidemiology
(January 2005)
Learning - Objectives
At the end of this session scholars must be able to:
1. List, define, and differentiate the various measures
of disease frequency e.g. prevalence, incidence, etc
2. Calculate disease frequency using above measures.
3. List the characteristics, uses and limitations of the
various measures.
Measures of Disease Frequency
Rates, Ratios, Proportion
Prevalence, Incidence,
Cumulative Incidence
Mortality, SMR,
Risk
Rate, Ratios and Proportion
Three general classes of mathematical
parameters
Often used to relate the number of cases of a
disease or health outcome to the size of the
source population in which they occurred.
Ratio
Is obtained by dividing one quantity (x) by
another Quantity (y). These quantities may be
related or may be totally independent.
Usually expressed as x
---- x 10n
y
Example: Number of females per 1000 males
# females
------------ x 1000
# males
Proportion
Is a ratio in which the numerator is included in the
denominator.
Example: The number of fetal deaths out of the total
number of births. The answer is often expressed as a
percentage
# of fetal deaths
------------------------------------- x 100
# of live births + fetal deaths
Rate
It is a measure of how quickly an event of interest
occurs.
It is calculated by dividing the number of cases by the
corresponding number of people in the population at
risk. It is usually expressed as cases per 10n.
Time, place and population must be specified for each
type of rate
Example: # cases of Typhoid in Chennai, Jan. 2005
--------------------------------------- x 10n
Population at risk in Chennai for Typhoid,
Jan. 2005
Population at Risk
Refers to that portion of a population which is
susceptible to a disease. Can be defined on the basis
of demographic or environmental factors.
Example: Population at risk of developing
carcinoma cervix is calculated as follows:
1. Total population minus all males
2. Total female population minus those
below 30 and above 70 years
Therefore population at risk of developing cancer
cervix includes all females aged 30-69 years
Prevalence – (P)
Prevalence is the number of existing cases (old and
new) in a defined population at a specified point of
time.
Prevalence rate for a disease is calculated as follows:
# people with disease or conditions at a specified time
P = -------------------------------------------------- x 10n
of people in the population at risk at the specified time
In many studies the total population in the study area
is used as an approximation since data on population
at risk are not available
Prevalence – (P) Contd
Point Prevalence:
When the data have been collected at one point in time
P = C / N
- where C = # of observed cases at time ‘t’
N = Population size at time ‘t’
Measures the frequency of disease at a given point in time
Prevalence – (P) Contd
Point Prevalence Contd.
Example: Suppose there are 150 persons in a
population and, on a certain day 15 are
ill with flu. What is the estimated
prevalence for this population?
P = 15 / 150 = 10%
Prevalence – (P) Contd
Period Prevalence (PP)
When the data are collected over a specified
period of time
PP = C + I / N Where:
C = # of prevalent cases at the beginning of the
time period
I = # of incident cases that develop during the
period
N = size of the population for this same time
period
Prevalence – (P) Contd
Period Prevalence (PP) Contd.
Example : Suppose we followed a population of 150
persons for one year, and 25 had a disease of interest
at the start of follow up and another 15 new cases
developed during the year.
Calculate the following :
Period Prevalence for the year
Point prevalence at the start of the period
Prevalence – (P) Contd
Period Prevalence (PP) Contd. - Example Contd.
PP = C + I / N = (25 + 15) / 150 = 0.27 or 27 %
P = C / N = 25 /150 = 0.17 or 17 %
Prevalence – (P) Contd
Factors Influencing Prevalence include the following:
Severity of the illness
Duration of the illness
Number of new cases
Prevalence – (P) Contd
Factors Increasing Prevalence
Long Duration of the illness
Increase in new cases of the illness
Low / poor cure rate of illness
In migration of cases
In migration of Susceptible people
Out migration of healthy people
Improved Case detection / Diagnostic facilities
Prevalence – (P) Contd
Factors Decreasing Prevalence
Shorter duration of illness
High case fatality rate associated with the disease
Decrease in new cases
In migration of healthy people
Out migration of cases
Improved cure rate of cases
Prevalence – (P) Contd
Uses of Prevalence Data
Assessing the need for health care and in the
planning of such services.
To measure the occurrence of conditions for which
the onset of disease may be gradual
Study of chronic diseases
Incidence – (I)
It is the number of new cases arising in a given
period in a specified population.
Incidence Rate is calculated as follows:
# people who get a disease in a specified period
I = ---------------------------------------------------------- x 10n
Sum of the length of time during which each
person in the population is at risk
The numerator refers only to first events of disease.
Time, i.e. day, month, year, should be specified.
Measures the rapidity with which new cases are
occurring in a population.
Basic Measures of Disease Frequency`
Number of New cases in a population
during a given period of time
Cumulative Incidence = ------------------------------------------------------
Population free of disease
at start of period
Risk
This assumes that the entire population at risk at the start of the study has
been followed-up for the time period of observation
Number of new cases in a population
during a given period
Incidence Density = ---------------------------------------------------------
Total Person-time of observation
True Rate & Average
Hypothetical example for Risk & Incidence Density
Hypothetical example for Risk & Incidence Density
Onset
Time (years)
   
1 2 3 4 End
Diag
Lost
-------------
Diag
--------------
Diag Died
1980 1981 1982 1983 1984 1985
x
x
x
x
x
x
Disease-free observation period x Marks Diagnosis of disease
-------------Time observed after diagnosis
One year Risk = 1/5 = 20%
Incidence Density =
= 0.33 cases per PY
= 33 cases per 100 PY
years
Person
cases
new

9
3
Computation of Person-Time (PT)
Fixed Cohort Dynamic Cohort
No new members added to the New members get added to the
population during follow-up. Population during follow-up.
PT=Sum of Disease-free (i) PT=No. of Individuals x Length
periods in all persons in of follow-up adjusting for
the cohort. Migration in and out.
If, however, No. of new entrants
Person-years approach assumes into cohort equals number who
the risk to remain constant leave, the cohort is in a steady state.
through the period of In such a cohort
observation. (ii) PT = Total Population x Length
of follow-up.
If, however, the individual follow-up periods vary substantially in both
Fixed & Dynamic cohorts we have to use Acturial (Life-Table) method for
computing risk (This will be dealt with later in the course.)
Incidence – (I) Contd.
Cumulative Incidence (CI)
Is a simpler measure of disease occurrence. It
measures the denominator only at the beginning of a
study
Cumulative Incidence rate is calculated as follows:
# people who get disease during a specified period
C I = -------------------------------------------------------------- x 10n
# people free of disease in the population at risk in
the beginning of the period
Is often expressed as cases per 1000 population
CI = I / N
Incidence – (I) Contd.
Cumulative Incidence (CI) Contd.
C I = I / N
I= # of new cases during follow-up
N = # of disease free subjects at start of follow up
Example: N = 1000 men aged 45 years ; I = 50
developed prostate cancer. Follow-up =10 years. No
one lost to follow up. No one withdrew from study.
CI = I /N = 50/1000 = 0.05 = 5 %
10 year risk = CI = I/N = 5%
Risk
It is the probability that an individual with certain
characteristics like age, race, sex, smoking status
will experience a health status change over a
specified follow – up period.
The concept assumes that the individual does not :
Have disease at the start of follow up
Die from other causes during follow up
Prevalence - Incidence
Prevalence depends on both the incidence rate and
the duration of the disease from onset to termination.
P = I x D
Change in prevalence from one time period to another
may be the result of changes in incidence rates,
changes in the duration of disease, or, both.
The relationship between prevalence and incidence
varies according to the disease. There may be high
prevalence and low incidence e.g. Diabetes Mellitus,
or low prevalence and high incidence - common cold
Mortality
Mortality data however crude provide information
on trends in a population’s health status.
The Crude mortality rate (CMR) is calculated thus:
# deaths in a specified period
CMR = ------------------------------------------------ x 10n
Average total population during
that period
CMR does not take into account factors such as
age, sex, race, socio economic status, etc.
Mortality Contd.
Standardized Mortality Ratio (SMR)
SMR is a ratio measure. It is calculated by dividing
the observed number of cases of disease in the
cohort by the expected number ( O / E ). It is usually
expressed as a percentage.
The expected number is calculated by applying age
specific standard disease rates from a reference
population ( e.g. national rates) to the age
distribution of the cohort
Some Examples of Incidence and Prevalence Measures
Rate Type Numerator Denominator______
Morbidity Incidence New cases of non- Mid-year population
fatal disease
Mortality Incidence No. of deaths from Mid-year population
all causes
Case-fatality Incidence No. of deaths from a No. of cases of that
disease disease
Attack Incidence No. of cases of a Total population at
disease risk for a limited
period of time
Disease at Prevalence No. of cases of a No. of persons
autopsy disease autopsied
Birth defect Prevalence No. of babies with No. of live births
a given abnormality
(Source: Epidemiology in Medicine; Charles H. Hennekins & Julie E. Buring)

More Related Content

Similar to 1.D.1.DiseFreq.ppt

Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
AbdallahAlasal1
 
Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
AbdallahAlasal1
 
Measurement of epidemiology.pptx
Measurement of epidemiology.pptxMeasurement of epidemiology.pptx
Measurement of epidemiology.pptx
radha maharjan
 
mudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfmudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdf
teddiyfentaw
 
Ch 15 Measures of morbidity..doc
Ch 15 Measures of morbidity..docCh 15 Measures of morbidity..doc
Ch 15 Measures of morbidity..doc
AbedurRahman5
 
Measurement of morbidity
Measurement of morbidityMeasurement of morbidity
Measurement of morbidity
drjagannath
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
ADIL .
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
amitakashyap1
 
1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density
A M
 
Epidemiology lecture3 incidence
Epidemiology lecture3 incidenceEpidemiology lecture3 incidence
Epidemiology lecture3 incidence
INAAMUL HAQ
 
Statistical epidemiology
Statistical  epidemiologyStatistical  epidemiology
Statistical epidemiology
Nandhini Sekar
 
Epidemiology of periodontal disease
Epidemiology of periodontal diseaseEpidemiology of periodontal disease
Epidemiology of periodontal disease
DR. OINAM MONICA DEVI
 
Measures Of Morbidity
Measures Of MorbidityMeasures Of Morbidity
Measures Of Morbidity
Ravi Prakash Verma
 
Measures of frequency 1
Measures of frequency 1Measures of frequency 1
Measures of frequency 1
Tumwebaze Mathias
 
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
mhosn627
 
Introduction to epidemiology and it's measurements
Introduction to epidemiology and it's measurementsIntroduction to epidemiology and it's measurements
Introduction to epidemiology and it's measurements
wrigveda
 
Epidemilogy
EpidemilogyEpidemilogy
Epidemilogy
Palwasha Khan
 
UNIT 3 MEASURES OF FREQUENCY.pdf
UNIT 3 MEASURES OF FREQUENCY.pdfUNIT 3 MEASURES OF FREQUENCY.pdf
UNIT 3 MEASURES OF FREQUENCY.pdf
JoyceSChipili
 
Basic epidemiologic concept
Basic epidemiologic conceptBasic epidemiologic concept
Basic epidemiologic concept
mehr92
 
4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt
OwomugishaMartin
 

Similar to 1.D.1.DiseFreq.ppt (20)

Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
 
Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
 
Measurement of epidemiology.pptx
Measurement of epidemiology.pptxMeasurement of epidemiology.pptx
Measurement of epidemiology.pptx
 
mudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfmudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdf
 
Ch 15 Measures of morbidity..doc
Ch 15 Measures of morbidity..docCh 15 Measures of morbidity..doc
Ch 15 Measures of morbidity..doc
 
Measurement of morbidity
Measurement of morbidityMeasurement of morbidity
Measurement of morbidity
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
 
1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density
 
Epidemiology lecture3 incidence
Epidemiology lecture3 incidenceEpidemiology lecture3 incidence
Epidemiology lecture3 incidence
 
Statistical epidemiology
Statistical  epidemiologyStatistical  epidemiology
Statistical epidemiology
 
Epidemiology of periodontal disease
Epidemiology of periodontal diseaseEpidemiology of periodontal disease
Epidemiology of periodontal disease
 
Measures Of Morbidity
Measures Of MorbidityMeasures Of Morbidity
Measures Of Morbidity
 
Measures of frequency 1
Measures of frequency 1Measures of frequency 1
Measures of frequency 1
 
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
 
Introduction to epidemiology and it's measurements
Introduction to epidemiology and it's measurementsIntroduction to epidemiology and it's measurements
Introduction to epidemiology and it's measurements
 
Epidemilogy
EpidemilogyEpidemilogy
Epidemilogy
 
UNIT 3 MEASURES OF FREQUENCY.pdf
UNIT 3 MEASURES OF FREQUENCY.pdfUNIT 3 MEASURES OF FREQUENCY.pdf
UNIT 3 MEASURES OF FREQUENCY.pdf
 
Basic epidemiologic concept
Basic epidemiologic conceptBasic epidemiologic concept
Basic epidemiologic concept
 
4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt
 

More from SujitKumarBehera16

RCTIntrod.pptx
RCTIntrod.pptxRCTIntrod.pptx
RCTIntrod.pptx
SujitKumarBehera16
 
leptospira.ppt
leptospira.pptleptospira.ppt
leptospira.ppt
SujitKumarBehera16
 
CONCEPT OF HEALTH.pptx
CONCEPT OF HEALTH.pptxCONCEPT OF HEALTH.pptx
CONCEPT OF HEALTH.pptx
SujitKumarBehera16
 
GEOPOLITICS AND HEALTH Anusree.pptx
GEOPOLITICS AND HEALTH  Anusree.pptxGEOPOLITICS AND HEALTH  Anusree.pptx
GEOPOLITICS AND HEALTH Anusree.pptx
SujitKumarBehera16
 
Theories of International Relations.pptx
Theories of International Relations.pptxTheories of International Relations.pptx
Theories of International Relations.pptx
SujitKumarBehera16
 
AIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptxAIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptx
SujitKumarBehera16
 
DEPARTMENT PROFILE Prof Gopalan.ppt
DEPARTMENT PROFILE Prof Gopalan.pptDEPARTMENT PROFILE Prof Gopalan.ppt
DEPARTMENT PROFILE Prof Gopalan.ppt
SujitKumarBehera16
 
EPH.pptx
EPH.pptxEPH.pptx
African_Trypanosomiasis 1.ppt
African_Trypanosomiasis 1.pptAfrican_Trypanosomiasis 1.ppt
African_Trypanosomiasis 1.ppt
SujitKumarBehera16
 
American Trypanosomiasis 2.ppt
American Trypanosomiasis 2.pptAmerican Trypanosomiasis 2.ppt
American Trypanosomiasis 2.ppt
SujitKumarBehera16
 
CUBA.ppt
CUBA.pptCUBA.ppt
1st year epidemiology.ppt
1st year epidemiology.ppt1st year epidemiology.ppt
1st year epidemiology.ppt
SujitKumarBehera16
 

More from SujitKumarBehera16 (12)

RCTIntrod.pptx
RCTIntrod.pptxRCTIntrod.pptx
RCTIntrod.pptx
 
leptospira.ppt
leptospira.pptleptospira.ppt
leptospira.ppt
 
CONCEPT OF HEALTH.pptx
CONCEPT OF HEALTH.pptxCONCEPT OF HEALTH.pptx
CONCEPT OF HEALTH.pptx
 
GEOPOLITICS AND HEALTH Anusree.pptx
GEOPOLITICS AND HEALTH  Anusree.pptxGEOPOLITICS AND HEALTH  Anusree.pptx
GEOPOLITICS AND HEALTH Anusree.pptx
 
Theories of International Relations.pptx
Theories of International Relations.pptxTheories of International Relations.pptx
Theories of International Relations.pptx
 
AIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptxAIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptx
 
DEPARTMENT PROFILE Prof Gopalan.ppt
DEPARTMENT PROFILE Prof Gopalan.pptDEPARTMENT PROFILE Prof Gopalan.ppt
DEPARTMENT PROFILE Prof Gopalan.ppt
 
EPH.pptx
EPH.pptxEPH.pptx
EPH.pptx
 
African_Trypanosomiasis 1.ppt
African_Trypanosomiasis 1.pptAfrican_Trypanosomiasis 1.ppt
African_Trypanosomiasis 1.ppt
 
American Trypanosomiasis 2.ppt
American Trypanosomiasis 2.pptAmerican Trypanosomiasis 2.ppt
American Trypanosomiasis 2.ppt
 
CUBA.ppt
CUBA.pptCUBA.ppt
CUBA.ppt
 
1st year epidemiology.ppt
1st year epidemiology.ppt1st year epidemiology.ppt
1st year epidemiology.ppt
 

Recently uploaded

Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 

Recently uploaded (20)

Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 

1.D.1.DiseFreq.ppt

  • 1. Measures of Disease Frequency Vidya Ramachandran National Institute Of Epidemiology (January 2005)
  • 2. Learning - Objectives At the end of this session scholars must be able to: 1. List, define, and differentiate the various measures of disease frequency e.g. prevalence, incidence, etc 2. Calculate disease frequency using above measures. 3. List the characteristics, uses and limitations of the various measures.
  • 3. Measures of Disease Frequency Rates, Ratios, Proportion Prevalence, Incidence, Cumulative Incidence Mortality, SMR, Risk
  • 4. Rate, Ratios and Proportion Three general classes of mathematical parameters Often used to relate the number of cases of a disease or health outcome to the size of the source population in which they occurred.
  • 5. Ratio Is obtained by dividing one quantity (x) by another Quantity (y). These quantities may be related or may be totally independent. Usually expressed as x ---- x 10n y Example: Number of females per 1000 males # females ------------ x 1000 # males
  • 6. Proportion Is a ratio in which the numerator is included in the denominator. Example: The number of fetal deaths out of the total number of births. The answer is often expressed as a percentage # of fetal deaths ------------------------------------- x 100 # of live births + fetal deaths
  • 7. Rate It is a measure of how quickly an event of interest occurs. It is calculated by dividing the number of cases by the corresponding number of people in the population at risk. It is usually expressed as cases per 10n. Time, place and population must be specified for each type of rate Example: # cases of Typhoid in Chennai, Jan. 2005 --------------------------------------- x 10n Population at risk in Chennai for Typhoid, Jan. 2005
  • 8. Population at Risk Refers to that portion of a population which is susceptible to a disease. Can be defined on the basis of demographic or environmental factors. Example: Population at risk of developing carcinoma cervix is calculated as follows: 1. Total population minus all males 2. Total female population minus those below 30 and above 70 years Therefore population at risk of developing cancer cervix includes all females aged 30-69 years
  • 9. Prevalence – (P) Prevalence is the number of existing cases (old and new) in a defined population at a specified point of time. Prevalence rate for a disease is calculated as follows: # people with disease or conditions at a specified time P = -------------------------------------------------- x 10n of people in the population at risk at the specified time In many studies the total population in the study area is used as an approximation since data on population at risk are not available
  • 10. Prevalence – (P) Contd Point Prevalence: When the data have been collected at one point in time P = C / N - where C = # of observed cases at time ‘t’ N = Population size at time ‘t’ Measures the frequency of disease at a given point in time
  • 11. Prevalence – (P) Contd Point Prevalence Contd. Example: Suppose there are 150 persons in a population and, on a certain day 15 are ill with flu. What is the estimated prevalence for this population? P = 15 / 150 = 10%
  • 12. Prevalence – (P) Contd Period Prevalence (PP) When the data are collected over a specified period of time PP = C + I / N Where: C = # of prevalent cases at the beginning of the time period I = # of incident cases that develop during the period N = size of the population for this same time period
  • 13. Prevalence – (P) Contd Period Prevalence (PP) Contd. Example : Suppose we followed a population of 150 persons for one year, and 25 had a disease of interest at the start of follow up and another 15 new cases developed during the year. Calculate the following : Period Prevalence for the year Point prevalence at the start of the period
  • 14. Prevalence – (P) Contd Period Prevalence (PP) Contd. - Example Contd. PP = C + I / N = (25 + 15) / 150 = 0.27 or 27 % P = C / N = 25 /150 = 0.17 or 17 %
  • 15. Prevalence – (P) Contd Factors Influencing Prevalence include the following: Severity of the illness Duration of the illness Number of new cases
  • 16. Prevalence – (P) Contd Factors Increasing Prevalence Long Duration of the illness Increase in new cases of the illness Low / poor cure rate of illness In migration of cases In migration of Susceptible people Out migration of healthy people Improved Case detection / Diagnostic facilities
  • 17. Prevalence – (P) Contd Factors Decreasing Prevalence Shorter duration of illness High case fatality rate associated with the disease Decrease in new cases In migration of healthy people Out migration of cases Improved cure rate of cases
  • 18. Prevalence – (P) Contd Uses of Prevalence Data Assessing the need for health care and in the planning of such services. To measure the occurrence of conditions for which the onset of disease may be gradual Study of chronic diseases
  • 19. Incidence – (I) It is the number of new cases arising in a given period in a specified population. Incidence Rate is calculated as follows: # people who get a disease in a specified period I = ---------------------------------------------------------- x 10n Sum of the length of time during which each person in the population is at risk The numerator refers only to first events of disease. Time, i.e. day, month, year, should be specified. Measures the rapidity with which new cases are occurring in a population.
  • 20. Basic Measures of Disease Frequency` Number of New cases in a population during a given period of time Cumulative Incidence = ------------------------------------------------------ Population free of disease at start of period Risk This assumes that the entire population at risk at the start of the study has been followed-up for the time period of observation Number of new cases in a population during a given period Incidence Density = --------------------------------------------------------- Total Person-time of observation True Rate & Average
  • 21. Hypothetical example for Risk & Incidence Density Hypothetical example for Risk & Incidence Density Onset Time (years)     1 2 3 4 End Diag Lost ------------- Diag -------------- Diag Died 1980 1981 1982 1983 1984 1985 x x x x x x Disease-free observation period x Marks Diagnosis of disease -------------Time observed after diagnosis
  • 22. One year Risk = 1/5 = 20% Incidence Density = = 0.33 cases per PY = 33 cases per 100 PY years Person cases new  9 3
  • 23. Computation of Person-Time (PT) Fixed Cohort Dynamic Cohort No new members added to the New members get added to the population during follow-up. Population during follow-up. PT=Sum of Disease-free (i) PT=No. of Individuals x Length periods in all persons in of follow-up adjusting for the cohort. Migration in and out. If, however, No. of new entrants Person-years approach assumes into cohort equals number who the risk to remain constant leave, the cohort is in a steady state. through the period of In such a cohort observation. (ii) PT = Total Population x Length of follow-up. If, however, the individual follow-up periods vary substantially in both Fixed & Dynamic cohorts we have to use Acturial (Life-Table) method for computing risk (This will be dealt with later in the course.)
  • 24. Incidence – (I) Contd. Cumulative Incidence (CI) Is a simpler measure of disease occurrence. It measures the denominator only at the beginning of a study Cumulative Incidence rate is calculated as follows: # people who get disease during a specified period C I = -------------------------------------------------------------- x 10n # people free of disease in the population at risk in the beginning of the period Is often expressed as cases per 1000 population CI = I / N
  • 25. Incidence – (I) Contd. Cumulative Incidence (CI) Contd. C I = I / N I= # of new cases during follow-up N = # of disease free subjects at start of follow up Example: N = 1000 men aged 45 years ; I = 50 developed prostate cancer. Follow-up =10 years. No one lost to follow up. No one withdrew from study. CI = I /N = 50/1000 = 0.05 = 5 % 10 year risk = CI = I/N = 5%
  • 26. Risk It is the probability that an individual with certain characteristics like age, race, sex, smoking status will experience a health status change over a specified follow – up period. The concept assumes that the individual does not : Have disease at the start of follow up Die from other causes during follow up
  • 27. Prevalence - Incidence Prevalence depends on both the incidence rate and the duration of the disease from onset to termination. P = I x D Change in prevalence from one time period to another may be the result of changes in incidence rates, changes in the duration of disease, or, both. The relationship between prevalence and incidence varies according to the disease. There may be high prevalence and low incidence e.g. Diabetes Mellitus, or low prevalence and high incidence - common cold
  • 28. Mortality Mortality data however crude provide information on trends in a population’s health status. The Crude mortality rate (CMR) is calculated thus: # deaths in a specified period CMR = ------------------------------------------------ x 10n Average total population during that period CMR does not take into account factors such as age, sex, race, socio economic status, etc.
  • 29. Mortality Contd. Standardized Mortality Ratio (SMR) SMR is a ratio measure. It is calculated by dividing the observed number of cases of disease in the cohort by the expected number ( O / E ). It is usually expressed as a percentage. The expected number is calculated by applying age specific standard disease rates from a reference population ( e.g. national rates) to the age distribution of the cohort
  • 30. Some Examples of Incidence and Prevalence Measures Rate Type Numerator Denominator______ Morbidity Incidence New cases of non- Mid-year population fatal disease Mortality Incidence No. of deaths from Mid-year population all causes Case-fatality Incidence No. of deaths from a No. of cases of that disease disease Attack Incidence No. of cases of a Total population at disease risk for a limited period of time Disease at Prevalence No. of cases of a No. of persons autopsy disease autopsied Birth defect Prevalence No. of babies with No. of live births a given abnormality (Source: Epidemiology in Medicine; Charles H. Hennekins & Julie E. Buring)